{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:26:28Z","timestamp":1791206788516,"version":"4.1.0"},"reference-count":25,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"abstract":"<jats:p>Skeletal dysplasias are a group of genetic disorders characterized by severe impairment of bone growth. Various forms of them add to produce a significant morbidity and mortality, yet no efficient drug therapy has been developed to date. We previously demonstrated that C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, is a potent stimulator of endochondral bone growth. Furthermore, we exhibited that targeted overexpression of a CNP transgene in the growth plate rescued the impaired bone growth observed in a mouse model of achondroplasia (Ach), the most frequent form of human skeletal dysplasias, leading us to propose that CNP may prove to be an effective treatment for this disorder. In the present study, to elucidate whether or not the systemic administration of CNP is a novel drug therapy for skeletal dysplasias, we have investigated the effects of plasma CNP on impaired bone growth in Ach mice that specifically overexpress CNP in the liver under the control of human serum amyloid P component promoter or in those treated with a continuous CNP infusion system. Our results demonstrated that increased plasma CNP from the liver or by iv administration of synthetic CNP-22 rescued the impaired bone growth phenotype of Ach mice without significant adverse effects. These results indicate that treatment with systemic CNP is a potential therapeutic strategy for skeletal dysplasias, including Ach, in humans.<\/jats:p>","DOI":"10.1210\/en.2008-1676","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T01:06:24Z","timestamp":1236906384000},"page":"3138-3144","source":"Crossref","is-referenced-by-count":112,"title":["Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal Dysplasias"],"prefix":"10.1210","volume":"150","author":[{"given":"Akihiro","family":"Yasoda","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetomo","family":"Kitamura","sequence":"first","affiliation":[{"name":"Fuji-Gotemba Research Laboratories (H.K., N.M.), Chugai Pharmaceutical Company, Limited, Gotemba, Shizuoka 412-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihito","family":"Fujii","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Murao","sequence":"first","affiliation":[{"name":"Fuji-Gotemba Research Laboratories (H.K., N.M.), Chugai Pharmaceutical Company, Limited, Gotemba, Shizuoka 412-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Miura","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotetsu","family":"Kanamoto","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasato","family":"Komatsu","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Arai","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuwa","family":"Nakao","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science (A.Y., T.F., E.K., M.M., N.K., Y.K., H.A., K.N.), Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2009,3,12]]},"reference":[{"key":"2020071612412965600_R1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ajmg.10233","article-title":"Molecular-pathogenetic classification of genetic disorders of the skeleton.","volume":"106","author":"Superti-Furga","year":"2001","journal-title":"Am J Med Genet"},{"key":"2020071612412965600_R2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia.","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"2020071612412965600_R3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"2020071612412965600_R4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00547160","article-title":"Limb lengthening in achondroplasia by Ilizarov\u2019s method.","volume":"12","author":"Cattaneo","year":"1988","journal-title":"Int Orthop"},{"key":"2020071612412965600_R5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ajmg.1320420508","article-title":"Growth hormone therapy in achondroplasia.","volume":"42","author":"Horton","year":"1992","journal-title":"Am J Med Genet"},{"key":"2020071612412965600_R6","first-page":"53","article-title":"Growth hormone therapy in achondroplasia.","volume":"53(Suppl 3)","author":"Seino","year":"2000","journal-title":"Horm Res"},{"key":"2020071612412965600_R7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat Med"},{"key":"2020071612412965600_R8","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide.","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612412965600_R9","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.1073\/pnas.0407894101","article-title":"Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.","volume":"101","author":"Tamura","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612412965600_R10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.","volume":"75","author":"Bartels","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2020071612412965600_R11","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1210\/jc.2007-1101","article-title":"Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.","volume":"92","author":"Hachiya","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612412965600_R12","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"2020071612412965600_R13","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1002\/rcm.3319","article-title":"Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography\/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up.","volume":"21","author":"Murao","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2020071612412965600_R14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/endo-129-2-1104","article-title":"C-type natriuretic peptide (CNP) in rats and humans.","volume":"129","author":"Komatsu","year":"1991","journal-title":"Endocrinology"},{"key":"2020071612412965600_R15","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1073\/pnas.95.5.2337","article-title":"Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide.","volume":"95","author":"Suda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612412965600_R16","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI117182","article-title":"Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.","volume":"93","author":"Ogawa","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612412965600_R17","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1210\/en.2002-220307","article-title":"Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.","volume":"143","author":"Miyazawa","year":"2002","journal-title":"Endocrinology"},{"key":"2020071612412965600_R18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0167-0115(91)90215-3","article-title":"Neutral endopeptidase 24.11 in rat peripheral tissues: comparative localization by \u2018ex vivo\u2019 and \u2018in vitro\u2019 autoradiography.","volume":"33","author":"Sales","year":"1991","journal-title":"Regul Pept"},{"key":"2020071612412965600_R19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0006-291X(90)92187-5","article-title":"N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain.","volume":"170","author":"Minamino","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612412965600_R20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1291\/hypres.21.7","article-title":"Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide.","volume":"21","author":"Igaki","year":"1998","journal-title":"Hypertens Res"},{"key":"2020071612412965600_R21","doi-asserted-by":"crossref","first-page":"14288","DOI":"10.1074\/jbc.C500024200","article-title":"A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn\/cn mouse.","volume":"280","author":"Tsuji","year":"2005","journal-title":"J Biol Chem"},{"key":"2020071612412965600_R22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jhered\/esm065","article-title":"Short-limbed dwarfism: slw is a new allele of Npr2 causing chondrodysplasia.","volume":"98","author":"Sogawa","year":"2007","journal-title":"J Hered"},{"key":"2020071612412965600_R23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2156-8-16","article-title":"A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice.","volume":"8","author":"Jiao","year":"2007","journal-title":"BMC Genet"},{"key":"2020071612412965600_R24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.peptides.2008.04.020","article-title":"Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab \u2212\/\u2212 mice.","volume":"29","author":"Yoder","year":"2008","journal-title":"Peptides"},{"key":"2020071612412965600_R25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2008.08.139","article-title":"Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification.","volume":"376","author":"Tsuji","year":"2008","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/7\/3138\/9005417\/endo3138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/150\/7\/3138\/9005417\/endo3138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T05:10:43Z","timestamp":1633237843000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/150\/7\/3138\/2456109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,12]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2008-1676","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,12]]}}}